Ubrelvy and Nurtec are prescription medications taken to treat migraines. Though they share similarities, Ubrelvy is for ...

Explore effective chronic migraine treatments, including medications, supplements, devices, and natural options. Discover how to manage migraine and improve your quality of life.

Bourla outlined 2025 priorities, which include improving R&D productivity, achieving margin expansion, and maintaining commercial excellence. He highlighted expectations for nine Phase 3 readouts, 13 ...

Pfizer Inc. (NYSE: PFE) reported financial results for fourth-quarter and full-year 2024 and reaffirmed its 2025 financial guidance(5) provided on December 17, 2024. The ...

Copaxone and Glatopa include a boxed warning due to the increased risk of life-threatening anaphylaxis (a severe allergic reaction) that can occur at any time after use, from the first dose to years ...

The estimate suggests a change of -39.1% year over year. According to the collective judgment of analysts, 'Revenue- Primary Care- Nurtec ODT/Vydura- Worldwide' should come in at $384.55 million.

Pfiz­er will pay near­ly $60 mil­lion to set­tle claims that its sub­sidiary Bio­haven used il­le­gal kick­backs to dri­ve sales of its mi­graine med­i­cine Nurtec ODT … ...

Pfizer will pay nearly $60 million to settle allegations that Biohaven, a company it acquired, paid kickbacks to healthcare professionals to encourage them to prescribe its migraine drug Nurtec ODT, ...

Pfizer ended the Nurtec speaker programs after paying $11.5 billion to buy Biohaven. "Patients deserve to know that their doctor is prescribing medications based on their doctor’s medical ...